Tribehenin

Tribehenin is a lipid of Glycerolipids (GL) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 850 references associated with Tribehenin in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for Tribehenin

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Tribehenin

MeSH term MeSH ID Detail
Edema D004487 152 associated lipids
Angina Pectoris D000787 27 associated lipids
Candidiasis, Vulvovaginal D002181 8 associated lipids
Total 3

NCBI Entrez Crosslinks

All references with Tribehenin

Download all related citations
Per page 10 20 50 100 | Total 169
Authors Title Published Journal PubMed Link
Zhang S et al. Engineering hot-melt extruded solid dispersion for controlled release of hydrophilic drugs. 2017 Eur J Pharm Sci pmid:28087352
Quintanar-Guerrero D et al. Adaptation and optimization of the emulsification-diffusion technique to prepare lipidic nanospheres. 2005 Eur J Pharm Sci pmid:16046105
Vaghasiya H et al. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. 2013 Eur J Pharm Sci pmid:23557842
Videira MA et al. Experimental design towards an optimal lipid nanosystem: a new opportunity for paclitaxel-based therapeutics. 2013 Eur J Pharm Sci pmid:23528739
Jannin V et al. Evaluation of the digestibility of solid lipid nanoparticles of glyceryl dibehenate produced by two techniques: Ultrasonication and spray-flash evaporation. 2018 Eur J Pharm Sci pmid:28966096
Bose S and Michniak-Kohn B Preparation and characterization of lipid based nanosystems for topical delivery of quercetin. 2013 Eur J Pharm Sci pmid:23246734
Aji Alex MR et al. Lopinavir loaded solid lipid nanoparticles (SLN) for intestinal lymphatic targeting. 2011 Eur J Pharm Sci pmid:20971188
Aburahma MH and Badr-Eldin SM Compritol 888 ATO: a multifunctional lipid excipient in drug delivery systems and nanopharmaceuticals. 2014 Expert Opin Drug Deliv pmid:25152197
Siram K et al. Solid lipid nanoparticles of diethylcarbamazine citrate for enhanced delivery to the lymphatics: in vitro and in vivo evaluation. 2014 Expert Opin Drug Deliv pmid:24847779
Soleimanian Y et al. Propolis wax nanostructured lipid carrier for delivery of β sitosterol: Effect of formulation variables on physicochemical properties. 2018 Food Chem pmid:29699688
Mukherjee S et al. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. 2009 Indian J Pharm Sci pmid:20502539
Wang G et al. Effects of quercetin nanoliposomes on C6 glioma cells through induction of type III programmed cell death. 2012 Int J Nanomedicine pmid:22275840
Lai F et al. SLN as a topical delivery system for Artemisia arborescens essential oil: in vitro antiviral activity and skin permeation study. 2007 Int J Nanomedicine pmid:18019840
Zhang H et al. Preparation, in vitro release, and pharmacokinetics in rabbits of lyophilized injection of sorafenib solid lipid nanoparticles. 2012 Int J Nanomedicine pmid:22787390
Chakraborty S et al. Inhibitory effect of a new orally active cedrol-loaded nanostructured lipid carrier on compound 48/80-induced mast cell degranulation and anaphylactic shock in mice. 2017 Int J Nanomedicine pmid:28744120
Chen YC et al. Development of terbinafine solid lipid nanoparticles as a topical delivery system. 2012 Int J Nanomedicine pmid:22923986
Urbán-Morlán Z et al. Preparation and characterization of solid lipid nanoparticles containing cyclosporine by the emulsification-diffusion method. 2010 Int J Nanomedicine pmid:20856836
Makwana V et al. Solid lipid nanoparticles (SLN) of Efavirenz as lymph targeting drug delivery system: Elucidation of mechanism of uptake using chylomicron flow blocking approach. 2015 Int J Pharm pmid:26367780
Martínez-Acevedo L et al. Evaluation of the lubricating effect of magnesium stearate and glyceryl behenate solid lipid nanoparticles in a direct compression process. 2018 Int J Pharm pmid:29729408
Gaspar DP et al. Rifabutin-loaded solid lipid nanoparticles for inhaled antitubercular therapy: Physicochemical and in vitro studies. 2016 Int J Pharm pmid:26656946